Today, mask intolerance and discomfort still represent a major cause of NIPPV failure. And here is another reason why it can be.
This paper published significant upper airway findings for patients who used Face-Mask NIV or Helmet NIV.
Great article with a quick summary and key points for Helmet-based ventilation. Keep in mind that Helmet CPAP and Helmet PSV are often lumped together under the broad umbrella of Non-invasive ventilation.
1. Helmet CPAP therapy markedly improves oxygenation in COVID patients and the intubation rate is lower in patients treated with Helmet therapy than in those treated with HFNO
2. Helmet CPAP is a safe and effective treatment option for immunocompromised patients with ARF
3. Helmet CPAP benefited patients (non-COVID) rescued by nurses in the absence of any pharmacological intervention, implying that CPAP should be used as a first-line intervention even before standard medical treatment!
CONCLUSIONS: In the subjects with COPD with exacerbation, NAVA through a helmet improved comfort, triggering performance, and patient-ventilator synchrony compared with pressure support through a face mask.
Aurika Savickaite RN, BSN - Rush University College of Nursing
Comments